Target Name: ZMYM5
NCBI ID: G9205
Review Report on ZMYM5 Target / Biomarker Content of Review Report on ZMYM5 Target / Biomarker
ZMYM5
Other Name(s): ZMYM5 variant 3 | zinc finger protein 237 | Zinc finger protein 198-like 1 | zinc finger MYM-type containing 5 | Zinc finger MYM-type protein 5 | zinc finger protein 198-like 1 | MYM | Zinc finger MYM-type containing 5, transcript variant 3 | Zinc finger protein 237 | ZMYM5_HUMAN | Zinc finger MYM-type protein 5 (isoform 3) | ZNF237 | ZNF198L1 | HSPC050 | zinc finger, MYM-type 5

ZMYM5: A Potential Drug Target Or Biomarker

ZMYM5 (ZMYM5 variant 3) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the ZMYM family of proteins, which are known for their role in cell signaling and inflammation. ZMYM5 is unique due to its unique variant form, which has been identified as ZMYM5 variant 3.

In recent years, ZMYM5 has gained significant interest as a potential drug target or biomarker due to its involvement in several diseases, including neurodegenerative disorders, cardiovascular diseases, and kidney diseases.

One of the defining features of ZMYM5 is its role in the regulation of the blood-brain barrier (BBB), which is a specialized barrier that separates the brain from the blood and ensures the delivery of essential nutrients and oxygen. The BBB is critical for the survival and functioning of the brain and has been implicated in numerous neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

ZMYM5 is known to play a key role in the regulation of the BBB and has been shown to contribute to the development and progression of these disorders. Studies have shown that ZMYM5 levels are elevated in individuals with Alzheimer's disease and that blocking its function may be a promising strategy for the treatment of this debilitating disorder.

In addition to its role in the BBB, ZMYM5 has also been implicated in the regulation of inflammation and has been shown to play a key role in the development of various inflammatory diseases, including cardiovascular diseases and neuroinflammatory disorders.

The ZMYM5 protein is also known to be involved in the regulation of cell signaling pathways, which are essential for the growth, division, and survival of cells. Studies have shown that ZMYM5 can interact with multiple signaling pathways and that its function in these pathways may be critical for the regulation of cellular processes that are important for human health and disease.

Given its involvement in so many different cellular processes, ZMYM5 has the potential to be a valuable drug target or biomarker for a wide range of diseases. Studies are currently being conducted to determine the full extent of ZMYM5's involvement in disease and to explore its potential as a drug or biomarker.

In conclusion, ZMYM5 (ZMYM5 variant 3) is a protein that is expressed in various tissues of the body and is involved in a wide range of cellular processes that are important for human health and disease. Its unique variant form and its involvement in the regulation of the blood-brain barrier and cell signaling pathways make it a promising target for drug development or biomarker research. Further studies are needed to fully explore its potential as a drug or biomarker.

Protein Name: Zinc Finger MYM-type Containing 5

Functions: Functions as a transcriptional regulator

The "ZMYM5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZMYM5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1